UBS Raises Price Target on Eli Lilly to $1,100 From $910, Maintains Buy Rating
Berenberg Maintains Buy on Eli Lilly and Co, Raises Price Target to $1000
Berenberg Adjusts Price Target on Eli Lilly & Co. to $1,000 From $850, Maintains Buy Rating
Eli Lilly and Co Analyst Ratings
Barclays Remains a Buy on Eli Lilly & Co (LLY)
Eli Lilly and Co Analyst Ratings
Goldman Sachs Adjusts Price Target on Eli Lilly & Co. to $793 From $785, Maintains Neutral Rating
Eli Lilly and Co Analyst Ratings
Eli Lilly and Co Analyst Ratings
Truist Securities Reiterates Buy on Eli Lilly and Co, Raises Price Target to $1000
Eli Lilly and Co Analyst Ratings
Jefferies Adjusts Price Target on Eli Lilly to $1,015 From $994
Eli Lilly and Co Analyst Ratings
Eli Lilly and Co Analyst Ratings
Eli Lilly and Co Analyst Ratings
Wells Fargo Reaffirms Their Buy Rating on Eli Lilly & Co (LLY)
Goldman Sachs Adjusts Price Target on Eli Lilly to $785 From $740
Jefferies Adjusts Price Target on Eli Lilly to $925 From $915
Eli Lilly and Co Analyst Ratings
Argus Adjusts Price Target on Eli Lilly to $840 From $770